[1] |
HU Yin, YANG Dandan, XU Yichao, SHAO Rong, RUAN Zourong, JIANG Bo, CHEN Jinliang, LOU Honggang.
Application of artificial neural network model in bioequivalence study of candesartan cilexetil tablets
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 63-69.
|
[2] |
CAI Mingmin, SHAO Jing, TANG Lu, SUN Qiuyue, DOU Ting, QIAN Wei, WANG Huiping.
Bioequivalence study of buthlphthalide injection in Chinese healthy volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 70-76.
|
[3] |
XU Guofang, ZHANG Sisen, LIU Ping, MEI Jiazhuan, LIU Weiwei, LIU Ya'ou, QI Qi.
Population pharmacokinetics of capecitabine in Chinese breast cancer patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 552-559.
|
[4] |
LIU Chang, DENG Kunhong, HUANG Jie, YANG Shuang, YANG Xiaoyan, XIANG Yuxia, HUANG Lu, ZHANG Zeyu, LIANG Wenzhong, LAN Jing, YANG Guoping.
Bioequivalence of moxifloxacin hydrochloride tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1393-1399.
|
[5] |
YANG Qinyan, HUANG Li, SHI Lan, OU Yuanyuan, LI Guoyuan, HUANG Chengyong.
Median effective plasma concentration of propofol inhibiting body movement when combined with butorphanol in patients undergoing hysteroscopic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1033-1037.
|
[6] |
GUO Mingxing, GUO Heng, SHEN Su, SUN Liying, CUI Xiangli.
Retrospective analysis of voriconazole in the monitoring of therapeutic drugs in patients with liver dysfunction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 757-763.
|
[7] |
CHEN Chao, ZHENG Qingshan, LI Lujin, LI Xue, XU Ling.
Comparison of the calculation approaches of AUC in non-compartment model pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1381-1387.
|
[8] |
XU Yichao, LOU Honggang, RUAN Zourong, CHEN Jinliang, JIANG Bo, SHAO Rong, YANG Dandan.
Bioequivalence of bosentan tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 675-680.
|
[9] |
WANG Mengyao,HUANG Jie, LIU Yanan, YANG Shuang, WU Shuting, YANG Xiaoyan, YE Ling, GUO Can, HUANG Zhijun.
Study on bioequivalence of gefitinib tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1275-1280.
|
[10] |
LI Li, LI He, LIU Xing'e, WEI Nan.
Determination of apatinib in tumor patients' plasma by liquid chromatography tandem mass spectrometry and its application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 790-795.
|
[11] |
CHEN Yaoyao,SHI Daohua,LIU Guanghua,NIU Peiguang,LIU Baichen.
Effects of OCT2 and MDR1 gene polymorphisms on vancomycin concentration and clinical efficacy in infants
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 154-158.
|
[12] |
NAN Feng, XU Nan, CHEN Zhihui, XIANG Jin, LIANG Maozhi, TAO Zeting, YE Wei.
Rapid and sensitive determination of amoxicillin in human plasma by LC-MS/MS and the bioavailability of two amoxicillin capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 73-77.
|
[13] |
LIU Shijia, CHEN Du, YIN Jungang, CHU Jihong, XU Meijuan, LIU Fang, DAI Guoliang, XIONG Ningning, JU Wenzheng.
Comparison of the pharmacokinetics of levetiracetam injection and levetiracetam tablets in human
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 294-298.
|
[14] |
CHEN Ya-jun, WANG Shu-jun, WANG Shan-shan, WANG Dian-lei, HE Li-qin, LI Jun-yao, YAN Dan-dan, WANG Xue-qi, LI Jie, PENG Zhao-liang.
Determination of glyco-gambogic acid and its pharmacokinetics in rat plasma by UPLC
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 374-378.
|
[15] |
XIA Zhi-gao, YANG Guo-ping, LIU Shi-kun, TAN Hong-yi, WANG Yan, WAN Qian, YANG Liu, YANG Shuang, YANG Xiao-yan, PEI Qi.
Pharmacokinetics of tolvaptan tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 424-429.
|